STUDIO CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) formally welcomed world-renowned myeloma clinician and researcher S. Vincent Rajkumar, MD as the foundation’s new Chairperson of the Board on Friday, February 2.
Dr. Rajkumar is a Professor of Medicine at the Mayo Clinic; a Member of the National Cancer Institute Myeloma Steering Committee; Chair of the Myeloma Committee, ECOG-ACRIN Cancer Research Group; Editor-in-Chief of Blood Cancer Journal; and Associate Editor of Leukemia, and the European Journal of Haematology. Dr. Rajkumar also served as principal investigator of several clinical trials for the treatment of myeloma, including pivotal trials that led to the regulatory approval of thalidomide for the treatment of the disease in the U.S. He has published more than 480 peer-reviewed papers primarily in the field of multiple myeloma and related plasma cell disorders.